ecNumber*1.3.8.8#specificActivity*-999#specificActivityMaximum*#commentary*heterozygous ACADVL mutation carriers show residual VLCAD activities of 23.7 to 54.2%; residual VLCAD activity of patients with confirmed VLCAD-deficiency is between 0.3 and 1.1%#organism*Homo sapiens#literature*700905#!ecNumber*1.3.8.8#specificActivity*0.00034#specificActivityMaximum*#commentary*crude extract, strain TH183, genotype fadR251(S), acetate and oleate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.00052#specificActivityMaximum*#commentary*crude extract, strain TH18, genotype fadR251(S), acetate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.00064#specificActivityMaximum*#commentary*crude extract, strain TH182, genotype fadR250(S) acetate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.00083#specificActivityMaximum*#commentary*crude extract, strain TH182, genotype fadR250(S), acetate and oleate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.0011#specificActivityMaximum*#commentary*crude extract, strain TH181, genotype fadR+, acetate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.00238#specificActivityMaximum*#commentary*MCAD activity, controls#organism*Homo sapiens#literature*700905#!ecNumber*1.3.8.8#specificActivity*0.0038#specificActivityMaximum*#commentary*crude extract, strain TH181, genotype fadR+, acetate and oleate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.0046#specificActivityMaximum*#commentary*crude extract, strain RS3010, genotype fadR1, acetate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.0055#specificActivityMaximum*#commentary*crude extract, strain RS3010, genotype fadR1, acetate and oleate as carbon source#organism*Escherichia coli#literature*394658#!ecNumber*1.3.8.8#specificActivity*0.00695#specificActivityMaximum*#commentary*VLCAD activity, controls, range 0.00195 to 0.01191#organism*Homo sapiens#literature*700905#!ecNumber*1.3.8.8#specificActivity*0.01241#specificActivityMaximum*#commentary*fibroblast homogenates, palmitoyl-CoA#organism*Homo sapiens#literature*394660#!ecNumber*1.3.8.8#specificActivity*0.06#specificActivityMaximum*#commentary*purified holoenzyme, arachidonoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*0.06037#specificActivityMaximum*#commentary*LCAD enzyme activity in livers of partially deficient LCAD mice 8 weeks after injection of recombinant adeno-associated viral mLCAD vector via the hepatic portal vein#organism*Mus musculus#literature*699301#!ecNumber*1.3.8.8#specificActivity*0.076#specificActivityMaximum*#commentary*purified enzyme, butyryl-CoA#organism*Bos taurus#literature*391361#!ecNumber*1.3.8.8#specificActivity*0.1#specificActivityMaximum*#commentary*purified holoenzyme, erucoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*0.1#specificActivityMaximum*#commentary*purified enzyme, butyryl-CoA#organism*Rattus norvegicus#literature*391282#!ecNumber*1.3.8.8#specificActivity*0.19#specificActivityMaximum*#commentary*purified enzyme, palmitoyl-CoA, 0.12 nmol/ml ETF#organism*Bos taurus#literature*391361#!ecNumber*1.3.8.8#specificActivity*0.2546#specificActivityMaximum*#commentary*LCAD enzyme activity in tibialis anterior muscle of LCAD-heterozygous deficient mice 10 weeks post-injection 1 x 10exp11 vg recombinant adeno-associated viral mLCAD#organism*Mus musculus#literature*699301#!ecNumber*1.3.8.8#specificActivity*0.259#specificActivityMaximum*#commentary*purified enzyme, palmitoyl-CoA, 0.24 nmol/ml ETF#organism*Bos taurus#literature*391361#!ecNumber*1.3.8.8#specificActivity*0.27#specificActivityMaximum*#commentary*purified enzyme, (R/S)-2-methylpalmitoyl-CoA#organism*Homo sapiens#literature*394665#!ecNumber*1.3.8.8#specificActivity*0.272#specificActivityMaximum*#commentary*purified enzyme, octanoyl-CoA#organism*Bos taurus#literature*391361#!ecNumber*1.3.8.8#specificActivity*0.3#specificActivityMaximum*#commentary*purified holoenzyme, docosanoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*0.34#specificActivityMaximum*#commentary*purified enzyme, (S)-2-methylpentadecanoyl-CoA#organism*Homo sapiens#literature*394665#!ecNumber*1.3.8.8#specificActivity*0.38#specificActivityMaximum*#commentary*purified holoenzyme, linolenoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*0.39#specificActivityMaximum*#commentary*purified enzyme, palmitoyl-CoA#organism*Homo sapiens#literature*394665#!ecNumber*1.3.8.8#specificActivity*0.7#specificActivityMaximum*#commentary*purified holoenzyme, octanoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*0.72#specificActivityMaximum*#commentary*purified holoenzyme, linoleoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*0.8#specificActivityMaximum*#commentary*purified enzyme, decanoyl-CoA#organism*Rattus norvegicus#literature*391282#!ecNumber*1.3.8.8#specificActivity*0.82#specificActivityMaximum*#commentary*purified enzyme, palmitoyl-CoA#organism*Rattus norvegicus#literature*391282#!ecNumber*1.3.8.8#specificActivity*0.9#specificActivityMaximum*#commentary*purified holoenzyme, eicosanoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*1.13#specificActivityMaximum*#commentary*purified holoenzyme, oleoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*1.48#specificActivityMaximum*#commentary*purified apoenzyme, palmitoyl-CoA#organism*Rattus norvegicus#literature*391270#!ecNumber*1.3.8.8#specificActivity*1.5#specificActivityMaximum*#commentary*purified holoenzyme, palmitoyl-CoA#organism*Rattus norvegicus#literature*391270#!ecNumber*1.3.8.8#specificActivity*1.5#specificActivityMaximum*#commentary*purified holoenzyme, decanoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*1.51#specificActivityMaximum*#commentary*purified holoenzyme, palmitoleoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*1.52#specificActivityMaximum*#commentary*purified apoenzyme, palmitoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*1.6#specificActivityMaximum*#commentary*purified holoenzyme, stearoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*1.8#specificActivityMaximum*#commentary*purified holoenzyme, dodecanoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*1.96#specificActivityMaximum*#commentary*purified holoenzyme, palmitoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*2.1#specificActivityMaximum*#commentary*purified holoenzyme, tetradecanoyl-CoA#organism*Rattus norvegicus#literature*391272#!ecNumber*1.3.8.8#specificActivity*15.27#specificActivityMaximum*#commentary*purified enzyme, decanoyl-CoA#organism*Homo sapiens#literature*391371#!ecNumber*1.3.8.8#specificActivity*32.5#specificActivityMaximum*#commentary*purified enzyme, decanoyl-CoA#organism*Bos taurus#literature*391275#